{Reference Type}: Journal Article
{Title}: Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives.
{Author}: Das T;Joseph J;Simunovic MP;Grzybowski A;Chen KJ;Dave VP;Sharma S;Staropoli P;Flynn H;
{Journal}: Prog Retin Eye Res
{Volume}: 97
{Issue}: 0
{Year}: 2023 11 12
{Factor}: 19.704
{DOI}: 10.1016/j.preteyeres.2023.101218
{Abstract}: Infectious endophthalmitis is a severe intraocular infection caused by bacteria, or less commonly by fungi. It can occur after penetrating eye procedures, trauma, or the spread of infection from contiguous structures or via emboli from distant organs. Because of the time-critical nature of the treatment, endophthalmitis is treated with the clinical diagnosis and modified by the microbiological report of the intraocular contents. The current strategy for managing endophthalmitis relies on pre-clinical literature, case series, and one large multi-center randomized clinical trial on post-cataract surgery endophthalmitis. Culture-susceptibility of the microorganisms from undiluted vitreous guides the definitive treatment in non-responsive cases. Strategies to reduce the incidence of endophthalmitis after penetrating eye procedures have been developed concurrently with refined means of treatment. Despite these advances, outcomes remain poor for many patients. Although consensus articles have been published on managing endophthalmitis, treatment patterns vary, and controversies remain. These include (1) the use of newer methods for early and precise microbiological diagnosis; (2) the choice of intravitreal antibiotics; (3) the need for systemic therapy; (4) early and complete vitrectomy. Here, we review the current consensus and address controversies in diagnosing and managing endophthalmitis. This review is intended to familiarize physicians and ophthalmologists with different aspects of endophthalmitis management to make informed decisions.